top of page
NETWORKING & COMMUNITY / LATEST NEWS
Do you have important news to share with us? ESGCT members are invited to send their news items to office@esgct.eu to share via our website and social media.
Fondazione Telethon announces submission of MAA to EMA for Gene Therapy for the treatment of Wiskott-Aldrich Syndrome patients
Read the press release here for full details.
Feb 5
School Event at the ESGCT 2024 Annual Congress
More than 1000 school students attended an event organised by Fondazione Telethon at the ESGCT Congress in Rome. Watch the event video here.
Jan 15
ESGCT 2024 HEADLINE NUMBERS
2024 was a busy year for ESGCT! See a summary of our headline numbers here.
Jan 8
E-Seminar - ATMP Research in South America - 02 December
Join the latest e-Seminar organised by the Coalition of International Gene Therapy Societies
Nov 21, 2024
Australasian Gene and Cell Therapy Society 13th Biennial Meeting
Aerial UTS Function Centre, Sydney, from 30 October - 1 November 2024.
Oct 7, 2024
E-Seminar - Coalition of International Gene Therapy Societies- 26 September
When: Thursday 26 September 2024 Australian Eastern Standard Time (AEST): 10.00 PM Central European Summer Time (CEST): 2.00 PM Eastern...
Sep 17, 2024
Call for Conference Grants: Apply Now for GenE-Humdi ITC Grants
Supporting the attendance and participation at the upcoming ESGCT Congress for students from ITC and NNC countries.
Aug 9, 2024
e-SEMINAR WITH FEDERICA ESPOSITO AND IVANA TRAPANI
Hosted as part of the AROUND THE WORLD SERIES in collaboration with the Coalition of International Gene Therapy Societies.
Jul 15, 2024
Momentum in Cell and Gene Therapy Symposium, June 19 in Evry
Please attend our upcoming event, the Momentum in Cell and Gene Therapy Symposium which is co-organized by ART-TG (Inserm) and...
Apr 23, 2024
New plan announced to get more children access to cutting-edge, proven gene therapy treatments for rare diseases
Great Ormond Street Hospital (GOSH), supported by LifeArc and Great Ormond Street Hospital Children’s Charity (GOSH Charity), has...
Apr 10, 2024
VIVEbiotech announces significant growth in 2023
San Sebastián, Spain, December 14, 2023 - VIVEbiotech, S.L., a GMP contract development and manufacturing organization (CDMO) full...
Dec 18, 2023
FDA Investigating Serious Risk of T-cell Malignancy
FDA Investigating Serious Risk of T-cell Malignancy Following BCMA-Directed or CD19-Directed Autologous Chimeric Antigen Receptor (CAR) T...
Nov 30, 2023
Nobel Prize in Medicine 2023
The ESGCT would like to congratulate Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that...
Oct 2, 2023
VIVEbiotech participates in the European MAGIC project
The MAGIC consortium is committed to making a meaningful impact on the lives of individuals affected by muscular dystrophies.
Jul 20, 2023
Abstract submission deadline for the ETRS-SPCE annual meeting has been extended to July 16
Annual meeting of the European Tissue Repair Society (ETRS) and Portuguese Society of Stem Cells and Cell Therapies (SPCE), October 2023.
Jul 12, 2023
Förderstiftung MHH plus awards Johann Georg Zimmermann Medal to LIT scientist Hinrich Abken
The prestigious Johann Georg Zimmermann Medal was awarded this year to LIT scientist Prof. Dr. Hinrich Abken.
Jun 30, 2023
Hildegard Büning first winner of the Exceptional Service Award
This award has been created to recognise individuals for their outstanding contribution to ESGCT and their commitment to Society’s...
Jun 2, 2023
13TH STEM CELL CLONALITY AND GENOME STABILITY RETREAT
OCTOBER 23, 2023 BRUSSELS, BELGIUM The Transatlantic Gene Therapy Consortium gladly invites you to join us at the 13th Stem Cell...
May 25, 2023
Seppo Yla-Herttuala winner of 2023 Outstanding Achievement Award
It is with great pleasure that the board of the ESGCT confers to professor Seppo Yla-Herttuala the award to his outstanding career....
May 11, 2023
GLOBAL AWARDS FOR RESEARCH IN DMD-AWARD
Pfizer Global Medical Grants have opened a request for proposals that advance our understanding of Duchenne muscular dystrophy.
Apr 28, 2023
INTERNATIONAL PRIMARY IMMUNODEFICIENCIES CONGRESS
November 8-10, 2023, Rotterdam.
Mar 31, 2023
WADA invites applications for research projects on the development of gene doping detection methods
The World Anti-Doping Agency (WADA) is pleased to inform you of a call for research projects on the theme of Gene Doping Detection that...
Feb 20, 2023
JOIN SFTCG'S WEBINAR SERIES ON GENE EDITING AND GENE THERAPY
SFTCG's next webinar series begins on 10 February with 'An introduction to gene editing for gene therapy applications'.
Feb 2, 2023
ESGCT 2022 HEADLINE NUMBERS
View a summary of our headline numbers and achievements in 2022.
Jan 11, 2023
ESGCT SUPPORTING MASTERS STUDENTS
See how the BME Paris Master's Programme students have benefitted from ESGCT activities!
Jan 11, 2023
SCIENTIFIC CALL FOR PROPOSALS AFM-TELETHON 2023
This INTERNATIONAL Call for Proposals, open to both French and foreign teams.
Dec 19, 2022
IMPORTANT NEWS TO SHARE WITH US?
ESGCT members are invited to send their news items to share via our website and social media.
Dec 12, 2022
FIRST CONDITIONAL MARKETING AUTHORIZATION APPROVAL IN THE EU FOR HEMOPHILIA "A" GENE THERAPY
Thierry VandenDriessche(1), Steven W Pipe(2), Glenn F Pierce(3), Radoslaw Kaczmarek(4) 1. Department of Gene Therapy & Regenerative...
Dec 12, 2022
NEW EUROPEAN CONSORTIUM - AGORA
A new Europe-wide academic initiative, named AGORA (Access to Gene therapies fOr RAre disease), has been launched.
Dec 12, 2022
ERC HORIZON EUROPE 2023 SUBMISSION DATES
€2.2 billion will be made available by the ERC in 2023 to allow over 1,000 top researchers to pursue frontier research.
Nov 1, 2022
REVIEW ARTICLE: TOWARDS ACCESS FOR ALL
1st Working Group Report for the Global Gene Therapy Initiative (GGTI).
Sep 21, 2022
IN MEMORY OF DR. MANFRED SCHMIDT
ESGCT would like to express our sadness and dismay at the loss of Dr. Manfred Schmidt.
Jan 26, 2022
REVIEW ON EX VIVO HSC GENE THERAPY FOR NATURE REV GENETICS
Review written by Alessandro Aiuti, Giuliana Ferrari & Adrian Thrasher.
Sep 23, 2020
OBITUARY NOTICE: PROFESSOR SHIGETAKA ASANO
The Japan Society of Gene and Cell Therapy has announced that Prof. Shigetaka Asano, the first president of JSGCT, passed away in Aug 2020.
Aug 31, 2020
bottom of page